Ernexa Therapeutics (ERNAW) Goodwill & Intangibles (2010 - 2026)

Ernexa Therapeutics (ERNAW) has 17 years of Goodwill & Intangibles data on file, last reported at $2.0 million in Q1 2026.

• Quarterly Goodwill & Intangibles changed 0.0% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (changed 0.0% YoY) and the FY2025 annual result came in at $2.0 million, changed 0.0% from the prior year.
• Goodwill & Intangibles slipped to $2.0 million in Q1 2026, from $2.0 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $8.0 million in Q1 2022 to a low of $2.0 million in Q3 2022.
• A 5-year average of $2.4 million and a median of $2.0 million in 2022 frame the typical range for Goodwill & Intangibles.
• The widest YoY moves for Goodwill & Intangibles: up 2.2% in 2023, down 75.14% in 2023.
• Tracing ERNAW's Goodwill & Intangibles over 5 years: stood at $2.0 million in 2022, then rose by 2.2% to $2.0 million in 2023, then changed by 0.0% to $2.0 million in 2024, then changed by 0.0% to $2.0 million in 2025, then fell by 2.15% to $2.0 million in 2026.
• The last three Goodwill & Intangibles figures came in at $2.0 million (Q1 2026), $2.0 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.